Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

81 results about "Immunoglobulin M" patented technology

Immunoglobulin M (IgM) is one of several isotypes of antibody (also known as immunoglobulin) that are produced by vertebrates. IgM is the largest antibody, and it is the first antibody to appear in the response to initial exposure to an antigen. In the case of humans and other mammals that have been studied, the spleen, where plasmablasts responsible for antibody production reside, is the major site of specific IgM production.

Electrochemical immunosensor for detecting toxoplasma gondii IgM antibody and preparation method thereof

The invention belongs to the technical field of analytical chemistry and chemical sensors and discloses an electrochemical immunosensor for detecting a toxoplasma gondii IgM (Immunoglobulin m) antibody (Tg-IgM) of a gravida and a preparation method of the electrochemical immunosensor. The immunosensor is prepared by sequentially modifying graphene, polythionine, gold nanoparticles and capture antigen to the surface of a glassy carbon electrode. An enzyme-functionalized nano-composite detection probe with an electrical signal amplifying function is prepared by assembling enzyme and a second antibody with high proportions on an Au-Fe3O4 surface. According to the sandwich immunoassay principle, the concentration of Tg-IgM is determined by using an electrochemical signal generated by catalysis of enzyme to a substrate. According to the electrochemical immunosensor, the specificity of immunoreaction is combined with the sensitivity of electrochemical detection; the transmission of electronics is promoted by using the graphene, the polythionine, the gold nanoparticles, Au-Fe3O4 and other material; and the sensitivity of the detection is improved. The electrochemical immunosensor has the advantages of simplicity and convenience for operation, favorable regeneration performance and detection cost reduction. The electrochemical immunosensor prepared on the basis can be also used for detecting other immunological markers and has favorable application prospect in medical diagnosis.
Owner:CHONGQING MEDICAL UNIVERSITY

Detection reagent of treponema pallidum IgM (Immunoglobulin M) antigen colloidal gold method and preparation method thereof

The invention discloses a detection reagent of a treponema pallidum IgM (Immunoglobulin M) antigen colloidal gold method and a preparation method thereof. The reagent comprises a gold conjugate pad (3), a cellulose nitrate reaction membrane (4), a sample pad (2), water absorbing paper (5) and a PVC (Polyvinyl Chloride) back lining (1), wherein the sample pad, the gold conjugate pad, the cellulose nitrate reaction membrane and the water absorbing paper are sequentially and mutually laminated and adhered on the PVC back lining; the sample pad is laminated on the gold conjugate pad for 2-3 mm, the gold conjugate pad is laminated on the cellulose nitrate reaction membrane for 2-3 mm, and the water absorbing paper is laminated on the cellulose nitrate reaction membrane for 2-3 mm; the gold conjugate pad is coated with an anti-human IgM monoclonal antibody-colloidal gold conjugate; and positions of a quality control region (7) and a detection region (6) of the cellulose nitrate reaction membrane are coated with goat anti-mouse IgG antibody or rabbit anti-mouse IgG antibody and specific gene recombinant treponema pallidum antigen respectively. A production process of a product provided by the invention is simple and easy to control; the detection reagent is easy, convenient and quick in detection; and a result can be read in 25 minutes and is not affected by the IgG antibody and is accurate and reliable.
Owner:BEIJING BIONEOVAN

Method and kit for performing quick co-detection on anti-human Hi (Haemophilus influenzae) IgM (Immunoglobulin M) and IgG (Immunoglobulin G) antibodies based on magnetic separation and multi-color quantum dot labeling

ActiveCN104181301AFast separationIt has the effect of synergistic amplification of multiple signalsFluorescence/phosphorescenceSerum igeMagnetic bead
The invention discloses a method and a kit for performing quick co-detection on anti-human Hi (Haemophilus influenzae) IgM (Immunoglobulin M) and IgG (Immunoglobulin G) antibodies based on magnetic separation and multi-color quantum dot labeling. The kit consists of anti-human Hi antibody capturing nano magnetic beads with an anti-human Hi IgM and IgG antibody gathering function, anti-human IgM and IgG antibody nano probes labeled by multi-color quantum dots, quality control substances and a PBST buffering solution, wherein the quality control substances comprise a positive quality control substance and a negative quality control substance; the positive quality control substance is serum, in which anti-human Hi IgM and IgG antibodies of human Hi infected people are respectively positive; the negative quality control substance is serum, in which anti-human Hi IgM and IgG are respectively negative. The kit and the method have the advantages of simplicity, quickness and high sensitivity, and can be used for carrying out synchronous detection on the anti-human Hi IgM and IgG antibodies.
Owner:HUBEI UNIV OF TECH +1

Chlamydia pneumoniae IgM (immunoglobulin M) colloidal golden method kit and preparation method thereof

InactiveCN102749446AObvious detectabilityReduce the effectMaterial analysisMurine antibodyChlamydiae
The invention discloses a chlamydia pneumoniae IgM (immunoglobulin M) colloidal golden method kit which comprises recombinant chlamydia pneumoniae antigens enveloped on a nitrocellulose membrane detection line, goat anti-rat IgG (immunoglobulin G) antibodies enveloped on a quality control line and rat anti-human IgM monoclonal antibodies which have colloidal gold labels and are enveloped on a gold label pad, the concentration of the chlamydia pneumoniae antigens ranges from 1mg/ml to 2mg/ml and is measured by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis), the concentration of the goat anti-rat IgG (immunoglobulin G) antibodies ranges from 1mg/ml to 3mg/ml, and the concentration of the rat anti-human IgM monoclonal antibodies ranges from 5g/mL to 30g/mL and is measured by the SDS-PAGE. The chlamydia pneumoniae IgM colloidal golden method kit has the advantages that the kid is speedy, simple, convenient and accurate and is high in sensitivity, and a judgment result can be read after integral operation time of dozens of minutes; and a colloidal gold quick detecting paper strip is made of the multi-epitope recombinant antigens and is simple and convenient to operate, low in cost, good in specificity and high in sensitivity, can be used for single-component detection and is popularized easily, and detection and control effects for chlamydia pneumoniae IgM are obvious.
Owner:北京中检安泰诊断科技有限公司

Detection test paper for quickly diagnosing Lyme disease, and preparation method thereof

The invention discloses detection test paper for quickly diagnosing the Lyme disease, and a preparation method thereof. A method for detecting the Lyme disease by ELISA (Enzyme Linked Immunosorbent Assay) is long in detection time and is not suitable for substrate detection. The colloidal gold immunochromatography detection test paper for quickly diagnosing the Lyme disease comprises a bottom plate, a sample cushion, a Jinbiao cushion, a nitrocellulose membrane and a water adsorption cushion, wherein the sample cushion, the Jinbiao cushion, the nitrocellulose membrane and the water adsorptioncushion are arranged and connected in sequence and are all arranged on the bottom plate; the nitrocellulose membrane is provided with a first detection line, a second detection line and a quality control line, wherein the first detection line is provided with a mouse anti-human IgM (Immunoglobulin M) monoclonal antibody, the second detection line is provided with a mouse anti-human IgG (Immunoglobulin G) monoclonal antibody, and the quality control line is provided with a goat anti-mouse IgG polyclonal antibody; and the Jinbiao cushion is provided with Lyme disease recombinant antigen-colloidal gold conjugate. The detection test paper has the advantages of short detection time, high detection accuracy, high specificity and convenience in operation, and does not need the help of other equipment instruments.
Owner:HANGZHOU ALLTEST BIOTECH

Colloidal gold test strip for fast detecting IgG and IgM antibodies of dengue fever virus

The invention discloses a colloidal gold test strip for fast detecting IgG (immunoglobulin G) and IgM (immunoglobulin M) antibodies of dengue fever virus and belongs to medical test consumables. The colloidal gold test strip is characterized in that 1-4 kinds of antigens are enveloped on a gold labeled protein-adsorbed fiber combination pad; the antigens are selected from four subtype antigens of the dengue fever virus labeld by colloidal gold; a polyclonal antibody of the antigens for resisting the dengue fever virus is enveloped on a quality control line C; an anti-mu chain monoclonal antibody is enveloped on a detection line T1, and an anti-human IgG monoclonal antibody is enveloped on a detection line T2. The test strip disclosed by the invention can fast detect serotype 1, 2, 3 and 4 type IgG and IgM antibodies of the dengue fever virus by adopting an antibody capture method combined with an immune colloidal gold technique and has the advantages of simplicity, sensitivity, specificity and accuracy. The test strip disclosed by the invention has the advantages of small sample quantity and wide storage condition, can save resources and can judge the positive result of the IgG or IgM antibody of the dengue fever virus once at the same time.
Owner:蓝十字生物药业(北京)有限公司 +1

Natural anti-oxidation low-density lipoprotein antibody for suppressing atherosclerosis

The invention belongs to the technical field of biomedicine, in particular to a natural anti-oxidation low-density lipoprotein (oxLDL) IgM subclass antibody for suppressing atherosclerosis. The natural anti-oxidation low-density lipoprotein (oxLDL) IgM subclass antibody is characterized in that a Babl/c rat is bred with a high-cholesterol diet for 4 weeks under a condition of no special pathogen;splenic cells (B cells primarily) are separated, the B cells and myeloma cells are combined by a chemical method, and hybridoma cells are obtained; and oxidized low-density lipoprotein (oxLDL) is usedas an antigen, an indirect enzyme-linked immunosorbent assay (ELISA) experiment is carried out on the growth holes of the positive hybridoma cells, positive cloning holes are determined, and the required cloning positive cells are screened out by a limiting dilution method. The obtained cloning positive cells are cloned and multiplied, cells generating a monoclonal antibody are obtained, and thenatural oxLDL-resisting immunoglobulin M (IgM) subclass antibody 3A6 is obtained. The antibody can be used for lowering the formation of the atherosclerosis of the rat and provides a novel idea and anovel method for researching the generation, the development and the treatment of the atherosclerosis.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Purification method of human immunoglobulin for intravenous injection

The invention discloses a purification method of human immunoglobulin for intravenous injection. The purification method is used for purification of a secondary sedimentation ingredient. The purification method of the human immunoglobulin for the intravenous injection is characterized by comprising the following steps of: S1, dissolve: dissolving the secondary sedimentation ingredient with water for injection, and stirring for 2-4h at 2.0-8.0 DEG C to form a dissolve liquid, S2, filtration: filtering the dissolve liquid with a 0.45 micrometers filter membrane and then with a 0.2 micrometers filter membrane to form a filtrate, S3: filtrate adjustment: adjusting a pH (potential of hydrogen) of the filtrate to 5.60-6.00, a protein concentration to 10-13g/L, and conductivity to 0.2-1.90ms/cm to form a pre-chromatography liquid, S4, chromatography: performing chromatography with strong anion exchange gel, flushing the gel before the chromatography for balancing to allow a difference betweena pH of the gel and a pH of the liquid before the chromatography to be from -0.10 to 0.10, performing gel chromatography sample loading at a linear flow rate of 0.5-1.5cm/min and chromatography loading capacity of not exceeding 600g/L, and collecting a liquid after the chromatography. The method is simple and controllable, and greatly reduces a content of IgA (immunoglobulin A) and IgM (immunoglobulin M) in the human immunoglobulin for the intravenous injection.
Owner:HUALAN BIOLOGICAL ENG CHONGQING +1

Fluorescent quantitative PCR (Polymerase Chain Reaction) primers for detecting mycoplasma pneumoniae (MP) and application thereof

The invention discloses fluorescent quantitative PCR (Polymerase Chain Reaction) primers for detecting mycoplasma pneumoniae (MP) and application thereof. A primer pair provided by the invention is specific to a 16SrRNA gene or ATPase gene of MP and can be a primer pair 1 (shown by a sequence 1 and a sequence 2) or a primer pair 2 (shown by a sequence 3 and a sequence 4) or a primer pair 3 (shown by a sequence 5 and a sequence 6). Shown by experiments, compared with other commercialized detection primers, IgM (Immunoglobulin M) antibody detection methods and culture methods, a method in which the primer pair provided by the invention can be used for carrying out fluorescent quantitative PCR detection on test samples has the advantage that the MP can be specifically detected without being interfered by four kinds of common pathogenic mycoplasmas which have a relatively close genetic relationship with the MP, as well as common respiratory tract bacteria and fungal pathogenic bacteria. The method can be used for qualitatively detecting the MP and detecting the MP quantitatively very well, is a quantitative PCR detection technology which is quick, is strong in specificity and high in sensitivity and is suitable for clinically detecting the MP of all strains, and has good detection effect and application value in clinical detection.
Owner:BEIJING CHAOYANG HOSPITAL CAPITAL MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products